AIB1 predicts bladder cancer outcome and promotes bladder cancer cell proliferation through AKT and E2F1

British Journal of Cancer

Volumn 108, Issue 7, 2013, Pages 1470-1479

  Tong, Z T ^a,b   Wei, J H ^b   Zhang, J X ^c   Liang, C Z ^a   Liao, B ^b   Lu, J ^b   Fan, S ^a   Chen, Z H ^b   Zhang, F ^a   Ma, H H ^a   Qian, W C ^a   Kong, L L ^a   Fang, Y ^b   Chen, W ^b   Xie, D ^b,c   Luo, J H ^b  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; PROTEIN KINASE B; STEROID RECEPTOR COACTIVATOR 3; TRANSCRIPTION FACTOR E2F1; TUMOR MARKER;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLADDER CANCER; CANCER CELL CULTURE; CANCER GROWTH; CANCER SURVIVAL; CANCER TISSUE; CARCINOGENICITY; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; COLONY FORMATION; CONTROLLED STUDY; DISEASE MARKER; FEMALE; G1 PHASE CELL CYCLE CHECKPOINT; GENE OVEREXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; TREATMENT OUTCOME; WESTERN BLOTTING;

AGED; ANIMALS; CARCINOMA, TRANSITIONAL CELL; CELL GROWTH PROCESSES; CELL LINE, TUMOR; E2F1 TRANSCRIPTION FACTOR; FEMALE; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MIDDLE AGED; NUCLEAR RECEPTOR COACTIVATOR 3; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-AKT; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS; URINARY BLADDER NEOPLASMS;

EID: 84876467321     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2013.81     Document Type: Article

References (35)

1. Anzick SL, Kononen J, Walker RL, Azorsa DO, Tanner MM, Guan XY, Sauter G, Kallioniemi OP, Trent JM, Meltzer PS (1997) AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science 277: 965-968. (Pubitemid 27366683)
2. Arimura A, van Peer M, Schroder AJ, Rothman PB (2004) The transcriptional co-activator p/CIP (NCoA-3) is up-regulated by STAT6 and serves as a positive regulator of transcriptional activation by STAT6. J Biol Chem 279: 31105-31112. (Pubitemid 39037772)
3. Dann CT, Alvarado AL, Hammer RE, Garbers DL (2006) Heritable and stable gene knockdown in rats. Proc Natl Acad Sci USA 103: 11246-11251. (Pubitemid 44156504)
4. DeGregori J, Kowalik T, Nevins JR (1995) Cellular targets for activation by the E2F1 transcription factor include DNA synthesis-and G1/S-regulatory genes. Mol Cell Biol 15: 4215-4224.
5. Eblin KE, Bredfeldt TG, Buffington S, Gandolfi AJ (2007) Mitogenic signal transduction caused by monomethylarsonous acid in human bladder cells: role in arsenic-induced carcinogenesis. Toxicol Sci 95: 321-330. (Pubitemid 46152604)
6. Ghadimi BM, Schrock E, Walker RL, Wangsa D, Jauho A, Meltzer PS, Ried T (1999) Specific chromosomal aberrations and amplification of the AIB1 nuclear receptor coactivator gene in pancreatic carcinomas. Am J Pathol 154: 525-536. (Pubitemid 29094102)
7. Gnanapragasam VJ, Leung HY, Pulimood AS, Neal DE, Robson CN (2001) Expression of RAC 3, a steroid hormone receptor co-activator in prostate cancer. Br J Cancer 85: 1928-1936. (Pubitemid 34775331)
8. Han SJ, DeMayo FJ, Xu J, Tsai SY, Tsai MJ, O'Malley BW (2006) Steroid receptor coactivator (SRC)-1 and SRC-3 differentially modulate tissue-specific activation functions of the progesterone receptor. Mol Endocrinol 20: 45-55. (Pubitemid 43011669)
9. Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics, 2010. CA Cancer J Clin 60: 277-300.
10. Konety B, Lotan Y (2008) Urothelial bladder cancer: biomarkers for detection and screening. Bju Int 102: 1234-1241.
11. Lee SK, Kim HJ, Na SY, Kim TS, Choi HS, Im SY, Lee JW (1998) Steroid receptor coactivator-1 coactivates activating protein-1-mediated transactivations through interaction with the c-Jun and c-Fos subunits. J Biol Chem 273: 16651-16654. (Pubitemid 28311685)
12. Liu MZ, Xie D, Mai SJ, Tong ZT, Shao JY, Fu YS, Xia WJ, Kung HF, Guan XY, Zeng YX (2008) Overexpression of AIB1 in nasopharyngeal carcinomas correlates closely with advanced tumor stage. Am J Clin Pathol 129: 728-734.
13. Louie MC, Zou JX, Rabinovich A, Chen HW (2004) ACTR/AIB1 functions as an E2F1 coactivator to promote breast cancer cell proliferation and antiestrogen resistance. Mol Cell Biol 24: 5157-5171. (Pubitemid 38738153)
14. Luo JH, Xie D, Liu MZ, Chen W, Liu YD, Wu GQ, Kung HF, Zeng YX, Guan XY (2008) Protein expression and amplification of AIB1 in human urothelial carcinoma of the bladder and overexpression of AIB1 is a new independent prognostic marker of patient survival. Int J Cancer 122: 2554-2561. (Pubitemid 351590489)
15. McKenna NJ, O'Malley BW (2002) Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 108: 465-474. (Pubitemid 34260872)
16. Muller H, Bracken AP, Vernell R, Moroni MC, Christians F, Grassilli E, Prosperini E, Vigo E, Oliner JD, Helin K (2001) E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis. Genes Dev 15: 267-285. (Pubitemid 32155143)
17. Oh A, List HJ, Reiter R, Mani A, Zhang Y, Gehan E, Wellstein A, Riegel AT (2004) The nuclear receptor coactivator AIB1 mediates insulin-like growth factor I-induced phenotypic changes in human breast cancer cells. Cancer Res 64: 8299-8308. (Pubitemid 39491768)
18. Oka N, Tanimoto S, Taue R, Nakatsuji H, Kishimoto T, Izaki H, Fukumori T, Takahashi M, Nishitani M, Kanayama HO (2006) Role of phosphatidylinositol-3 kinase/Akt pathway in bladder cancer cell apoptosis induced by tumor necrosis factor-related apoptosis-inducing ligand. Cancer Sci 97: 1093-1098. (Pubitemid 44322559)
19. Pelucchi C, Bosetti C, Negri E, Malvezzi M, La Vecchia C (2006) Mechanisms of disease: the epidemiology of bladder cancer. Nat Clin Pract Urol 3: 327-340. (Pubitemid 43871794)
20. Qin L, Liao L, Redmond A, Young L, Yuan Y, Chen H, O'Malley BW, Xu J (2008) The AIB1 oncogene promotes breast cancer metastasis by activation of PEA3-mediated matrix metalloproteinase 2 (MMP2) and MMP9 expression. Mol Cell Biol 28: 5937-5950.
21. Ren B, Cam H, Takahashi Y, Volkert T, Terragni J, Young RA, Dynlacht BD (2002) E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints. Genes Dev 16: 245-256. (Pubitemid 34075816)
22. Sakakura C, Hagiwara A, Yasuoka R, Fujita Y, Nakanishi M, Masuda K, Kimura A, Nakamura Y, Inazawa J, Abe T, Yamagishi H (2000) Amplification and over-expression of the AIB1 nuclear receptor co-activator gene in primary gastric cancers. Int J Cancer 89: 217-223. (Pubitemid 30430736)
23. Tong ZT, Cai MY, Wang XG, Kong LL, Mai SJ, Liu YH, Zhang HB, Liao YJ, Zheng F, Zhu W, Liu TH, Bian XW, Guan XY, Lin MC, Zeng MS, Zeng YX, Kung HF, Xie D (2012) EZH2 supports nasopharyngeal carcinoma cell aggressiveness by forming a co-repressor complex with HDAC1/HDAC2 and Snail to inhibit E-cadherin. Oncogene 31: 583-594.
24. Torres-Arzayus MI, de Mora JF, Yuan J, Vazquez F, Branson R, Rue M, Sellers WR, Brown M (2004) High tumor incidence and activation of the PI3K/AKT pathway in transgenic mice define AIB1 as an oncogene. Cancer Cell 6: 263-274. (Pubitemid 39222039)
25. Trimarchi JM, Lees JA (2002) Sibling rivalry in the E2F family. Nat Rev Mol Cell Bio 3: 11-20. (Pubitemid 135709914)
26. Wang Y, Wu MC, Sham JST, Zhang WG, Wu WQ, Guan XY (2002) Prognostic significance of c-myc and AIB1 amplification in hepatocellular carcinoma-a broad survey using high-throughput tissue microarray. Cancer 95: 2346-2352. (Pubitemid 35351141)
27. Werbajh S, Nojek I, Lanz R, Costas MA (2000) RAC-3 is a NF-kappa B coactivator. Febs Lett 485: 195-199.
28. Xie D, Sham JS, Zeng WF, Lin HL, Bi J, Che LH, Hu L, Zeng YX, Guan XY (2005) Correlation of AIB1 overexpression with advanced clinical stage of human colorectal carcinoma. Hum Pathol 36: 777-783. (Pubitemid 41112033)
29. Xu FP, Xie D, Wen JM, Wu HX, Liu YD, Bi J, Lv ZL, Zeng YX, Guan XY (2007) SRC-3/AIB1 protein and gene amplification levels in human esophageal squamous cell carcinomas. Cancer Lett 245: 69-74. (Pubitemid 44959338)
30. Xu JM, Liao L, Ning C, Yoshida-Komiya H, Deng CX, O'Malley BW (2000) The steroid receptor coactivator SRC-3 (p/CIP/RAC3/AIB1/ACTR/TRAM-1) is required for normal growth, puberty, female reproductive function, and mammary gland development. Proc Natl Acad Sci 97: 6379-6384. (Pubitemid 30412722)
31. Yan J, Yu CT, Ozen M, Ittmann M, Tsai SY, Tsai MJ (2006) Steroid receptor coactivator-3 and activator protein-1 coordinately regulate the transcription of components of the insulin-like growth factor/AKT signaling pathway. Cancer Res 66: 11039-11046. (Pubitemid 44877004)
32. Ying H, Furuya F, Willingham MC, Xu J, O'Malley BW, Cheng SY (2005) Dual functions of the steroid hormone receptor coactivator 3 in modulating resistance to thyroid hormone. Mol Cell Biol 25: 7687-7695. (Pubitemid 41170130)
33. Zhou G, Hashimoto Y, Kwak I, Tsai SY, Tsai MJ (2003) Role of the steroid receptor coactivator SRC-3 in cell growth. Mol Cell Biol 23: 7742-7755. (Pubitemid 37271472)
34. Zhou HJ, Yan J, Luo WP, Ayala G, Lin SH, Erdem H, Ittmann M, Tsai SY, Tsai NJ (2005) SRC-3 is required for prostate cancer cell proliferation and survival. Cancer Res 65: 7976-7983. (Pubitemid 41297277)
35. Zou JX, Zhong Z, Shi XB, Tepper CG, deVere White RW, Kung HJ, Chen H (2006) ACTR/AIB1/SRC-3 and androgen receptor control prostate cancer cell proliferation and tumour growth through direct control of cell cycle genes. Prostate 66: 1474-1486. (Pubitemid 44465814)